WallStSmart
SAVA

Cassava Sciences Inc

NASDAQ: SAVA · HEALTHCARE · BIOTECHNOLOGY

$1.45
+0.69% today

Updated 2026-04-30

Market cap
$142.03M
P/E ratio
P/S ratio
2.54x
EPS (TTM)
$-2.22
Dividend yield
52W range
$1 – $5
Volume
0.5M

Cassava Sciences Inc (SAVA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+59.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-10.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-15.3%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-03$0.00+100.0%$2.32$2.21-4.7%
2025-11-13$-0.22+18.5%$3.26$2.76-15.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.27$0.00+100.0%
2025-09-30$-0.27$-0.22+18.5%$840000.00
2025-06-30$0.00$-0.92
2025-03-31$-0.48
2024-12-31$-0.68$-0.57+16.2%$1.22M-48.0%
2024-09-30$-0.88$-0.58+34.1%
2024-06-30$-0.40$0.13+132.5%
2024-03-31$-0.46$0.58+226.1%
2023-12-31$-0.52$-0.50+3.8%$2.35M
2023-09-30$-0.77$-0.61+20.8%
2023-06-30$-0.59$-0.63-6.8%
2023-03-31$-0.56$-0.58-3.6%
2022-12-31$-0.56$-0.47+16.1%

Frequently asked questions

Has Cassava Sciences Inc beaten earnings estimates?
Cassava Sciences Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +59.3% over the last 2 quarters.
How does SAVA stock react to earnings?
SAVA stock has moved an average of -10.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.